SCHEMBL21591739

SCHEMBL21591739

COc1cc(CCOS(C)(=O)=O)c(CCNC(=O)OC(C)(C)C)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1B P49286 3/20 0.41
MTNR1A P48039 2/20 0.41
NQO2 P16083 1/20 0.41
CA1 P00915 6/20 0.39
CA2 P00918 6/20 0.39
CA12 O43570 5/20 0.39
CA9 Q16790 5/20 0.39
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 1/20 0.36
GLA P06280 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36
HSD17B10 Q99714 1/20 0.36
DYRK1A Q13627 1/20 0.36
IDO1 P14902 2/20 0.35
STK17B O94768 1/20 0.35
STK17A Q9UEE5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21591747 0.85 MTNR1B (0.46) MTNR1BMTNR1ANQO2HTTNPSR1
SCHEMBL8288755 0.83 ATR (0.34) MTNR1BMTNR1ACA1CA2CA12
SCHEMBL28517134 0.82 MTNR1A (0.41) MTNR1BMTNR1ANQO2CA1CA2
SCHEMBL21591738 0.80 NQO2 (0.40) MTNR1BMTNR1ANQO2CA1CA2
SCHEMBL23854684 0.79 MTNR1B (0.46) MTNR1BMTNR1ANQO2CA1CA2
SCHEMBL23854724 0.78 MTNR1B (0.48) MTNR1BMTNR1ANQO2HTTNPSR1
SCHEMBL30570606 0.78 MTNR1B (0.48) MTNR1BMTNR1ANQO2HTTNPSR1
SCHEMBL21591730 0.78 NPC1 (0.43) MTNR1BMTNR1ANQO2HTTNPSR1
SCHEMBL23854682 0.77 MTNR1B (0.45) MTNR1BMTNR1ANQO2HTTNPSR1
SCHEMBL21594070 0.76 MTNR1B (0.42) MTNR1BMTNR1ANQO2HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807270-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
WO-2019238616-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed